Abrupt Relapse of ALK-Positive Lymphoma after Discontinuation of Crizotinib

被引：62
作者：
Gambacorti-Passerini, Carlo [1 ]
Mussolin, Lara [2 ]
Brugieres, Laurence [3 ]
机构：
[1] Univ Milano Bicocca, Monza, Italy
[2] Univ Padua, Padua, Italy
[3] Gustave Roussy Canc Campus, Villejuif, France
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 374卷 / 01期
关键词：
LARGE-CELL LYMPHOMA;
D O I：
10.1056/NEJMc1511045
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：95 / 96
页数：2
相关论文
共 5 条
  • [1] Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib
    Gambacorti-Passerini, Carlo
    Antolini, Laura
    Mahon, Francois-Xavier
    Guilhot, Francois
    Deininger, Michael
    Fava, Carmen
    Nagler, Arnon
    Della Casa, Chiara Maria
    Morra, Enrica
    Abruzzese, Elisabetta
    D'Emilio, Anna
    Stagno, Fabio
    le Coutre, Philipp
    Hurtado-Monroy, Rafael
    Santini, Valeria
    Martino, Bruno
    Pane, Fabrizio
    Piccin, Andrea
    Giraldo, Pilar
    Assouline, Sarit
    Durosinmi, Muheez A.
    Leeksma, Onno
    Pogliani, Enrico Maria
    Puttini, Miriam
    Jang, Eunjung
    Reiffers, Josy
    Valsecchi, Maria Grazia
    Kim, Dong-Wook
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (07): : 553 - 561
  • [2] Crizotinib in Anaplastic Large-Cell Lymphoma
    Gambacorti-Passerini, Carlo
    Messa, Cristina
    Pogliani, Enrico M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (08) : 775 - 776
  • [3] Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
    Mosse, Yael P.
    Lim, Megan S.
    Voss, Stephan D.
    Wilner, Keith
    Ruffner, Katherine
    Laliberte, Julie
    Rolland, Delphine
    Balis, Frank M.
    Maris, John M.
    Weigel, Brenda J.
    Ingle, Ashish M.
    Ahern, Charlotte
    Adamson, Peter C.
    Blaney, Susan M.
    [J]. LANCET ONCOLOGY, 2013, 14 (06) : 472 - 480
  • [4] Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL
    Mussolin, L.
    Bonvini, P.
    Ait-Tahar, K.
    Pillon, M.
    Tridello, G.
    Buffardi, S.
    Lombardi, A.
    Pulford, K.
    Rosolen, A.
    [J]. LEUKEMIA, 2009, 23 (02) : 400 - 402
  • [5] Crizotinib in Advanced, Chemoresistant Anaplastic Lymphoma Kinase-Positive Lymphoma Patients
    Passerini, Carlo Gambacorti
    Farina, Francesca
    Stasia, Alessandra
    Redaelli, Sara
    Ceccon, Monica
    Mologni, Luca
    Messa, Cristina
    Guerra, Luca
    Giudici, Giovanni
    Sala, Elena
    Mussolin, Lara
    Deeren, Dries
    King, Michael H.
    Steurer, Michael
    Ordemann, Rainer
    Cohen, Amos M.
    Grube, Matthias
    Bernard, Lea
    Chiriano, Gianpaolo
    Antolini, Laura
    Piazza, Rocco
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (02):
1